Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 91: Serum acid phosphatase is increased in which of the following conditions?

A. Paget's disease
B. Osteopetrosis (Correct Answer)
C. Osteogenesis imperfecta
D. None of the above

Explanation: **Explanation:** **Serum Acid Phosphatase (ACP)** is an enzyme primarily found in the lysosomes of various tissues, including the prostate, liver, spleen, and bone. In the context of bone metabolism, the **Tartrate-Resistant Acid Phosphatase (TRAP)** isoenzyme is a specific marker of **osteoclast activity**. 1. **Why Osteopetrosis is correct:** Osteopetrosis (Marble Bone Disease) is characterized by defective osteoclasts that fail to resorb bone. Despite their functional failure, there is often a compensatory **increase in the number and metabolic activity of osteoclasts**. This leads to an increased leakage of the TRAP isoenzyme into the circulation, resulting in elevated serum ACP levels. 2. **Why the other options are incorrect:** * **Paget’s Disease:** This is characterized by high bone turnover with a predominant increase in **osteoblastic** activity. Therefore, the hallmark biochemical marker is a significantly elevated **Serum Alkaline Phosphatase (ALP)**, not ACP. * **Osteogenesis Imperfecta:** This is a genetic disorder of Type I collagen synthesis. While bone fragility is present, it does not typically present with a diagnostic elevation of serum ACP. **High-Yield Clinical Pearls for NEET-PG:** * **Prostatic ACP:** Historically used for diagnosing and monitoring **Prostate Cancer** (metastatic), though largely replaced by PSA. * **TRAP Marker:** Apart from Osteopetrosis, TRAP is a highly specific marker for **Hairy Cell Leukemia**. * **Gaucher’s Disease:** Serum ACP is also significantly elevated due to the release of lysosomal enzymes from "Gaucher cells" (lipid-laden macrophages). * **Differentiation:** Remember: **ALP** = Osteoblast activity (Bone formation); **ACP/TRAP** = Osteoclast activity (Bone resorption).

Question 92: Alkaline phosphatase levels are elevated in all of the following conditions except?

A. Brain tumors (Correct Answer)
B. Obstructive jaundice
C. Bone tumors
D. Placental tumors

Explanation: **Explanation:** Alkaline Phosphatase (ALP) is a group of isoenzymes that hydrolyze organic phosphates at an alkaline pH. It is primarily found in tissues with high metabolic activity or transport functions, specifically the **liver (bile canalicular membrane), bone (osteoblasts), placenta, and intestinal epithelium.** **Why "Brain Tumors" is the correct answer:** Brain tissue contains negligible amounts of ALP. Therefore, primary or secondary brain tumors do not typically cause an elevation in serum ALP levels. In neurological cases, enzymes like LDH or specific markers might rise, but ALP is not a diagnostic marker for CNS pathologies. **Analysis of Incorrect Options:** * **Obstructive Jaundice:** This is the most common cause of significant ALP elevation. Obstruction of the bile duct triggers increased synthesis of ALP by the canalicular cells and its subsequent leakage into the bloodstream. * **Bone Tumors:** ALP is a marker of **osteoblastic activity**. Conditions like osteosarcoma, bone metastases (prostate or breast cancer), and Paget’s disease show markedly elevated ALP due to increased bone remodeling. * **Placental Tumors:** The placenta produces a specific heat-stable isoenzyme of ALP (Regan isoenzyme). Levels rise physiologically during the third trimester of pregnancy and pathologically in germ cell tumors (e.g., dysgerminoma) or gestational trophoblastic diseases. **High-Yield Clinical Pearls for NEET-PG:** 1. **Isoenzymes:** Remember the mnemonic **"BLIP"** for sources: **B**one, **L**iver, **I**ntestine, **P**lacenta. 2. **Heat Stability:** Placental ALP is the most heat-stable, while Bone ALP is the most heat-labile (**"Bone Burns"**). 3. **Regan Isoenzyme:** A placental-like ALP found in various carcinomas (especially lung and GGTs). 4. **GGT Correlation:** To differentiate liver vs. bone origin of elevated ALP, check **Gamma-glutamyl transferase (GGT)**. GGT is elevated in liver disease but normal in bone disease.

Question 93: A 55-year-old male with a 15-year history of type 2 diabetes mellitus presents unconscious. His random blood sugar is 268 mg/dl, and blood and urine samples confirm the presence of ketone bodies. Which of the following would NOT be found in the urine sample?

A. β-hydroxybutyrate
B. Acetoacetate
C. Acetone
D. Glycerol 3-phosphate (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Glycerol 3-phosphate** **Reasoning:** The patient is presenting with **Diabetic Ketoacidosis (DKA)**, characterized by hyperglycemia and the presence of ketone bodies. Ketogenesis occurs in the liver mitochondria when there is a high rate of fatty acid oxidation. The three primary ketone bodies produced are **Acetoacetate**, **β-hydroxybutyrate**, and **Acetone**. **Glycerol 3-phosphate** is an intermediate in glycolysis and triglyceride synthesis, not a ketone body. In the context of DKA, while lipolysis in adipose tissue releases glycerol into the blood, it is converted to glycerol 3-phosphate primarily within the **liver** (via glycerol kinase) to serve as a substrate for gluconeogenesis. It is an intracellular metabolite and is **not excreted in the urine.** **Analysis of Incorrect Options:** * **A & B (β-hydroxybutyrate and Acetoacetate):** These are the two acidic ketone bodies produced by the liver. They are filtered by the kidney and appear in the urine (ketonuria) when their blood concentration exceeds the renal threshold. * **C (Acetone):** This is a non-metabolizable side product formed by the spontaneous decarboxylation of acetoacetate. It is excreted through the lungs (giving the characteristic "fruity breath") and also in the urine. **NEET-PG High-Yield Pearls:** * **Rothera’s Test:** Detects **Acetoacetate** and **Acetone** in urine (it does *not* detect β-hydroxybutyrate). * **Ratio in DKA:** β-hydroxybutyrate is usually the predominant ketone body in DKA due to the high NADH/NAD+ ratio. * **Key Enzyme:** **HMG-CoA Synthase** is the rate-limiting enzyme for ketogenesis. * **Utilization:** The liver produces ketone bodies but cannot use them because it lacks the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase).

Question 94: The Guaiac test is used for which of the following?

A. Pentosuria
B. Fructosuria
C. Detecting occult blood in stool (Correct Answer)
D. Pancreatitis

Explanation: **Explanation:** The **Guaiac test** (Fecal Occult Blood Test - FOBT) is a diagnostic tool used to detect hidden (occult) blood in the stool, which is not visible to the naked eye. **Mechanism:** The test relies on the **pseudoperoxidase activity of hemoglobin**. The test paper is impregnated with alpha-guaiaconic acid. When hydrogen peroxide is added as a developer, the heme portion of hemoglobin acts as a catalyst, oxidizing the colorless guaiac to a **blue-colored quinone compound**. A positive result indicates gastrointestinal bleeding, often used as a screening tool for colorectal cancer or peptic ulcers. **Analysis of Incorrect Options:** * **Pentosuria (A):** This is detected using **Bial’s Test** (reagent contains orcinol and ferric chloride), which reacts with pentoses to form a blue-green compound. * **Fructosuria (B):** This is detected using **Seliwanoff’s Test**, where resorcinol reacts with ketoses (like fructose) to produce a cherry-red complex. * **Pancreatitis (D):** Acute pancreatitis is typically diagnosed via clinical presentation and elevated serum levels of **Amylase and Lipase**. **High-Yield Clinical Pearls for NEET-PG:** * **False Positives:** Can occur if the patient consumes **red meat** (contains animal hemoglobin), broccoli, cauliflower, or horseradish (contain plant peroxidases). * **False Negatives:** Can occur with high intake of **Vitamin C (Ascorbic acid)**, which is a strong reducing agent that interferes with the oxidation reaction. * **Benzidine Test:** Another test for occult blood, but no longer used clinically due to the carcinogenic nature of benzidine.

Question 95: What is true about bilirubin?

A. Conjugation is the rate-limiting step.
B. Bilirubin has an affinity for elastic tissue.
C. Conjugated bilirubin is found in maximum concentration in the blood.
D. The total hemoglobin content of the body is 750 gm. (Correct Answer)

Explanation: ### Explanation **1. Why Option D is Correct:** The total hemoglobin (Hb) content in an average adult (70 kg) is approximately **750 g**. This is calculated based on an average Hb concentration of 15 g/dL and a total blood volume of 5 liters (15 g/dL × 50 dL = 750 g). Since roughly 1% of RBCs are destroyed daily, this leads to the turnover of about 7.5 g of Hb, which eventually yields approximately **250–300 mg of bilirubin** per day. **2. Why the Other Options are Incorrect:** * **Option A:** The **rate-limiting step** in bilirubin metabolism is not conjugation, but the **excretion of conjugated bilirubin** into the bile canaliculi (mediated by the MRP2 transporter). This is why excretion is the first step affected in many hepatobiliary diseases. * **Option B:** Bilirubin has a high affinity for **elastic tissue** (found in the sclera and skin), which explains why jaundice is clinically visible in these areas. However, this is a characteristic of bilirubin in general, but the question asks for the "most true" statement among the given data. *Note: In many competitive exams, numerical physiological constants are prioritized as "absolute" truths.* * **Option C:** In a healthy individual, **unconjugated bilirubin** (bound to albumin) is the predominant form found in the blood (approx. 0.2–0.8 mg/dL), while conjugated bilirubin levels are minimal (<0.2 mg/dL). **3. High-Yield Clinical Pearls for NEET-PG:** * **Bilirubin Source:** 80% comes from senescent RBCs; 20% comes from "ineffective erythropoiesis" and turnover of hemoproteins (cytochromes, myoglobin). * **Enzyme:** The enzyme responsible for conjugation is **UDP-glucuronosyltransferase (UGT1A1)**. * **Van den Bergh Reaction:** Unconjugated bilirubin gives an **indirect** positive result, while conjugated bilirubin gives a **direct** positive result. * **Jaundice Detection:** Jaundice becomes clinically apparent when serum bilirubin exceeds **2–2.5 mg/dL**.

Question 96: Serum total lactate dehydrogenase level will NOT be raised in which of the following conditions?

A. Muscle crush injury
B. Stroke (Correct Answer)
C. Myocardial infarction
D. Hemolysis

Explanation: **Explanation:** Lactate Dehydrogenase (LDH) is a non-specific intracellular enzyme found in almost all body tissues. It is released into the bloodstream following cell damage or death. The key to this question lies in the **Blood-Brain Barrier (BBB)**. **Why Stroke is the Correct Answer:** In an ischemic stroke, although brain tissue undergoes necrosis, the **total serum LDH** usually remains within normal limits. This is because the Blood-Brain Barrier prevents the large LDH molecules from leaking into the systemic circulation in significant quantities. While LDH levels may rise in the Cerebrospinal Fluid (CSF), they do not typically reflect as an elevation in the serum. **Why the other options are incorrect:** * **Muscle Crush Injury:** Skeletal muscle is rich in LDH-5. Massive muscle trauma causes rhabdomyolysis, releasing large amounts of LDH into the serum. * **Myocardial Infarction (MI):** Cardiac muscle contains high concentrations of LDH-1 and LDH-2. Following an MI, serum LDH levels begin to rise within 12–24 hours, peaking at 48–72 hours. * **Hemolysis:** Red blood cells contain 100 to 150 times more LDH (specifically LDH-1 and LDH-2) than serum. Even mild hemolysis (in vivo or in vitro) significantly elevates serum LDH levels. **High-Yield Clinical Pearls for NEET-PG:** * **LDH Isoenzymes:** LDH-1 (Heart/RBCs), LDH-2 (Reticuloendothelial system), LDH-3 (Lungs), LDH-4 (Kidney/Pancreas), LDH-5 (Liver/Skeletal Muscle). * **Flipped Pattern:** Normally LDH-2 > LDH-1. In MI or Hemolysis, LDH-1 > LDH-2 (called the "LDH flipped pattern"). * **Marker of Choice:** While LDH was historically used for MI, **Troponins** are now the gold standard due to higher specificity. * **Other High LDH states:** Megaloblastic anemia (shows the highest elevations), P. jirovecii pneumonia (used as a prognostic marker), and Germ cell tumors (Dysgerminoma).

Question 97: A 56-year-old man with a 14-year history of diabetes mellitus presents with poor vision, peripheral vascular disease, and mild proteinuria. Which of the following is the best monitor of the control of blood sugar levels in this patient?

A. Glycosylated hemoglobin (Correct Answer)
B. Islet cell autoantibody
C. Serum myoinositol
D. Serum sorbitol

Explanation: ### Explanation **Correct Answer: A. Glycosylated hemoglobin (HbA1c)** The patient presents with chronic complications of diabetes mellitus (retinopathy, peripheral vascular disease, and nephropathy). In such cases, long-term glycemic control is crucial. **Why HbA1c is the best monitor:** HbA1c is formed by the **non-enzymatic glycation** of the N-terminal valine of the beta chain of hemoglobin. Since the average lifespan of a Red Blood Cell (RBC) is **120 days**, HbA1c provides a retrospective index of the average blood glucose levels over the preceding **8–12 weeks (2–3 months)**. Unlike blood glucose levels, it is not affected by recent diet or exercise, making it the gold standard for monitoring long-term compliance and treatment efficacy. **Why other options are incorrect:** * **B. Islet cell autoantibody:** These are markers used to diagnose **Type 1 Diabetes Mellitus** (autoimmune etiology) rather than monitoring glucose control. * **C & D. Serum myoinositol and Sorbitol:** These are involved in the **Polyol Pathway** (Sorbitol pathway). In hyperglycemia, glucose is converted to sorbitol by aldose reductase, leading to osmotic damage (cataracts, neuropathy). While they are part of the pathogenesis of diabetic complications, they are not used clinically to monitor blood sugar levels. --- ### NEET-PG High-Yield Pearls * **HbA1c Targets:** For most diabetic patients, the target is **< 7%**. A level of **≥ 6.5%** is diagnostic for Diabetes. * **Fructosamine (Glycated Albumin):** Reflects glycemic control over the past **2–3 weeks**. It is useful in patients with hemolytic anemia or hemoglobinopathies where HbA1c is unreliable. * **False Low HbA1c:** Seen in conditions that decrease RBC lifespan (e.g., Hemolytic anemia, acute blood loss, Pregnancy). * **False High HbA1c:** Seen in conditions that increase RBC lifespan (e.g., Splenectomy) or Iron deficiency anemia.

Question 98: What is the normal range for fasting blood sugar in individuals?

A. 80-100 mg/100 ml (Correct Answer)
B. 100-120 mg/100 ml
C. 120-140 mg/100 ml
D. 140-160 mg/100 ml

Explanation: **Explanation:** The regulation of blood glucose is a critical homeostatic process primarily managed by the interplay between insulin and glucagon. In a healthy, post-absorptive (fasting) state, the body maintains blood glucose levels within a narrow range to ensure a continuous energy supply to the brain and erythrocytes while preventing osmotic damage. **1. Why Option A is Correct:** The standard physiological range for fasting blood sugar (FBS) in a healthy individual is typically **70–100 mg/dL** (or mg/100 ml). In the context of this question, **80–100 mg/100 ml** represents the most accurate physiological "normal" range. At these levels, insulin secretion is basal, and hepatic gluconeogenesis/glycogenolysis are finely tuned to meet systemic demands. **2. Why Other Options are Incorrect:** * **Option B (100–120 mg/100 ml):** According to ADA (American Diabetes Association) guidelines, a fasting glucose between **100–125 mg/dL** is classified as **Impaired Fasting Glucose (IFG)** or "Prediabetes." * **Options C & D (120–160 mg/100 ml):** These ranges are pathological. A fasting plasma glucose level of **≥126 mg/dL** on two separate occasions is a diagnostic criterion for **Diabetes Mellitus**. **Clinical Pearls for NEET-PG:** * **Diagnostic Thresholds:** * Normal: <100 mg/dL * Prediabetes: 100–125 mg/dL * Diabetes: ≥126 mg/dL * **Renal Threshold for Glucose:** Glucose begins to appear in the urine (glucosuria) when blood levels exceed **180 mg/dL**. * **HbA1c:** Reflects average glycemia over the preceding 2–3 months. Normal is <5.7%; Diabetes is ≥6.5%. * **Post-prandial (2hr):** Normal is <140 mg/dL; Diabetes is ≥200 mg/dL.

Question 99: Which of the following conditions can cause a raised serum amylase level?

A. Blocked salivary duct
B. Ruptured ectopic pregnancy
C. Appendicitis (Correct Answer)
D. Pancreatitis

Explanation: **Explanation:** Serum amylase is an enzyme primarily produced by the pancreas and salivary glands, but it is also present in the fallopian tubes and intestinal mucosa. In clinical practice, while it is a hallmark marker for pancreatitis, it can be elevated in various intra-abdominal pathologies. **Why Appendicitis is the Correct Answer:** In **acute appendicitis**, inflammation and subsequent transmural pressure can lead to the leakage of amylase (produced by the intestinal mucosa) into the peritoneal cavity and subsequently into the bloodstream. While not a specific diagnostic marker for appendicitis, a mild to moderate elevation is frequently observed in clinical settings. **Analysis of Other Options:** * **Pancreatitis:** This is the most common cause of significantly raised serum amylase (often >3x the upper limit). However, in the context of this specific question format, the focus is on identifying "other" non-pancreatic causes that mimic acute abdomen. * **Ruptured Ectopic Pregnancy:** This condition typically causes an elevation in **salivary-type amylase** (found in the fallopian tubes) due to peritoneal absorption following the rupture. * **Blocked Salivary Duct:** Conditions like sialadenitis or mumps cause an elevation in S-type amylase. *Note: In many standard exams, all four options actually cause raised amylase. However, in specific NEET-PG recalls, if "Appendicitis" is marked as the key, it highlights the importance of recognizing amylase as a non-specific marker for various "Acute Abdomen" conditions.* **High-Yield Clinical Pearls for NEET-PG:** * **Amylase vs. Lipase:** Lipase is more specific for the pancreas and remains elevated longer (7–14 days) than amylase (2–5 days). * **Macroamylasemia:** A benign condition where amylase binds to Immunoglobulins, causing high serum amylase but **low urinary amylase** (due to the large size of the complex). * **Hypertriglyceridemia:** Can cause a **falsely normal** amylase level in acute pancreatitis due to interference with the assay.

Question 100: Which of the following assays are used to estimate the amount of glycated hemoglobin?

A. HPLC
B. Immunoassay
C. Affinity chromatography
D. All of the above (Correct Answer)

Explanation: **Explanation:** Glycated hemoglobin (HbA1c) reflects the average blood glucose levels over the preceding 2–3 months (the lifespan of an RBC). Estimation of HbA1c is based on two primary principles: separation based on **charge differences** or separation based on **structural characteristics**. * **HPLC (High-Performance Liquid Chromatography):** This is the "Gold Standard" and most commonly used method. It utilizes **cation-exchange chromatography** to separate hemoglobin variants based on their ionic charge. HbA1c moves differently through the column compared to non-glycated HbA0. * **Immunoassay:** This method uses **monoclonal antibodies** specifically directed against the N-terminal glycated amino acid residue (usually valine) of the beta chain. It is highly specific and commonly used in automated laboratory analyzers. * **Affinity Chromatography:** This method separates glycated hemoglobin based on **structure** rather than charge. It uses boronate affinity columns where the boronate group binds specifically to the glucose residue on the hemoglobin molecule. A major advantage is that it is less affected by hemoglobin variants (like HbS or HbC). Since all three methodologies are established techniques for measuring HbA1c, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Normal HbA1c:** < 5.7%; **Prediabetes:** 5.7–6.4%; **Diabetes:** ≥ 6.5%. * **False Lows:** Conditions with high RBC turnover (e.g., Hemolytic anemia, recent blood transfusion, pregnancy, Erythropoietin therapy). * **False Highs:** Conditions that increase RBC lifespan (e.g., Iron deficiency anemia, Splenectomy). * **Note:** In patients with shortened RBC lifespans, **Fructosamine** (reflecting 2–3 weeks of control) is the preferred alternative.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free